Niaprazine, famotidine, scopolamine, which are H1R, H2R and, H3R antagonists, respectively, showed behavioural improvement in ASD [9], schizophrenia (SCH) [10], Alzheimer’s disease (AD), and narcolepsy [13]. Here, HRH3 is linked to early-onset autosomal dominant Alzheimer disease.